Characteristic,Gross margin
Novo Nordisk,82.6%
Amgen,81.3%
Biogen,81%
Gilead,79.1%
Lilly,78.8%
AbbVie,77.1%
AstraZenca,72.4%
Pfizer,71.5%
Roche,71.3%
Merck & Co.,70.2%
Novartis,69.6%
GlaxoSmithKline,67.8%
Johnson & Johnson,67%
Bristol-Myers Squibb,66%
Sanofi,60.5%
Endo,46.3%
Teva,44.6%
Mylan,36.4%
